Davis Capital Management
MDLN icon

Davis Capital Management’s Medline Inc MDLN Stock Holding History

Davis Capital Management’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$278 Buy
8
+7
+700% +$256 ﹤0.01% 772
2026
Q2 		$39 Buy
+1
New +$40 ﹤0.01% 1246

Other funds holding MDLN

Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
H&F Corporate Investors X
H&F Corporate Investors X San Francisco, California $2.46B AUM 15.37% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Egerton Capital (UK)
Egerton Capital (UK) London, United Kingdom $9.8B AUM 22.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Davis Capital Management's MDLN Position: Q3 2026 in Review

Davis Capital Management increased its Medline Inc (MDLN) stake by 700% in Q3 2026, buying an estimated $256 and bringing the position to 8 shares worth $278. The position accounts for ﹤0.01% of the portfolio, ranked #772.

Davis Capital Management first reported a position in MDLN in Q2 2026 and has held it in 2 quarters since. 214 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Davis Capital Management held 8 shares of Medline Inc worth $278 as of Q3 2026.
  • Davis Capital Management bought 7 Medline Inc shares in Q3 2026, an estimated $256.
  • Medline Inc made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #772 holding.
  • Davis Capital Management first reported a position in Medline Inc in Q2 2026 and has held it in 2 quarters since.
  • 214 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.